Back
CASI Pharmaceuticals Stock Predictions
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CASI
CASI Pharmaceuticals
Last Price:
3.72
Seasonality Move:
4.2%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.CASI Pharmaceuticals Stock Forecast
-
Is CASI Pharmaceuticals Stock Undervalued?
The current CASI Pharmaceuticals [CASI] share price is $3.95. The Score for CASI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will CASI Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
CASI Pharmaceuticals Stock Rating
Data Unavailable
CASI Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
casipharmaceuticals.com
52-Week Data
52-Week High:
8.48
52-Week Low:
2.05
Prediction Charts
Market Cap:
61.04M
Price in USD:
3.95
Volume:
32.94K
Beta:
1.46
Technical Analysis
SMA50:
5.55
SMA100:
6.09
SMA200:
4.91
52-Wk Change:
-29.37%
Stock Predictions
-
Is CASI Pharmaceuticals stock public?
Yes, CASI Pharmaceuticals is a publicly traded company. -
What is the CASI Pharmaceuticals stock quote today?
The CASI Pharmaceuticals stock price is 3.95 USD today. -
How to buy CASI Pharmaceuticals stock online?
You can buy CASI Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-12 | 5.28 | 5.60 | 5.88 | 5.21 |
| Nov-13 | 5.50 | 5.55 | 5.65 | 5.25 |
| Nov-14 | 5.26 | 5.88 | 5.89 | 5.26 |
| Nov-15 | 5.51 | 5.33 | 5.95 | 5.31 |
| Nov-18 | 5.48 | 5.62 | 5.69 | 5.26 |
| Nov-19 | 5.36 | 5.34 | 5.69 | 5.30 |
| Nov-20 | 5.36 | 5.26 | 5.52 | 4.77 |
| Nov-21 | 5.20 | 5.25 | 5.32 | 5.20 |
| Nov-22 | 5.16 | 5.10 | 5.31 | 5.00 |
| Nov-25 | 4.93 | 4.29 | 5.14 | 4.08 |
| Nov-26 | 4.35 | 4.14 | 4.48 | 4.12 |
| Nov-27 | 4.10 | 3.97 | 4.18 | 3.97 |
| Nov-29 | 4.04 | 3.80 | 4.10 | 3.53 |
| Dec-2 | 3.83 | 3.95 | 4.00 | 3.61 |
CASI Pharmaceuticals Earnings
Data Unavailable
CASI Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
* CASI Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.